generated: '2026-09-02'
method: searched
source: https://www.vergentbio.com/
description: >-
  Vergent Bioscience publishes no plans, pricing, tiers, quotas or purchase path of any kind.
  It is a clinical-stage biotechnology company; its lead product, abenacianine for injection
  (VGT-309), is an investigational imaging agent that has not been approved by the FDA for
  any indication, so it is not sold. The site has no pricing page and no signup or login.
plan_count: 0
plans: []
evidence:
  - url: https://www.vergentbio.com/
    status: 200
    note: >-
      Full site navigation harvested: Our Technology, Therapeutic Focus, About Us, News,
      Contact Us, Investors, Publications, Expanded Access, Clinical Summary. No Pricing,
      Plans, products-for-sale, Sign Up or Login destination exists.
  - url: https://www.vergentbio.com/sitemap.xml
    status: 200
    note: 'Sitemap index served; no pricing, plans, or account URL in the site structure.'
notes:
  - >-
    Not a sales gate and not a thin measurement — this company has nothing priced. Recorded
    as a real zero rather than omitted, and no Pricing or SignUp pointer is emitted.